Avanos Medical, Inc. (AVNS)
USD 12.71
(-5.33%)
USD 12.71
(-5.33%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 121.4 Million USD | -20.29% |
| 2022 | 152.3 Million USD | 120.72% |
| 2021 | 69 Million USD | -49.75% |
| 2020 | 137.3 Million USD | 14.32% |
| 2019 | 120.1 Million USD | 187.79% |
| 2018 | -136.8 Million USD | -137.87% |
| 2017 | 361.2 Million USD | -22.37% |
| 2016 | 465.3 Million USD | 3.72% |
| 2015 | 448.6 Million USD | -7.92% |
| 2014 | 487.2 Million USD | 1613.04% |
| 2013 | -32.2 Million USD | -215.0% |
| 2012 | 28 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 126.1 Million USD | -9.22% |
| 2024 Q1 | 138.9 Million USD | 14.42% |
| 2024 Q3 | 73 Million USD | -10.23% |
| 2023 Q3 | 199.6 Million USD | 15.98% |
| 2023 Q4 | 121.4 Million USD | -39.18% |
| 2023 FY | 121.4 Million USD | -20.29% |
| 2023 Q1 | 159.7 Million USD | 4.86% |
| 2023 Q2 | 172.1 Million USD | 7.76% |
| 2022 Q3 | 187.2 Million USD | -6.12% |
| 2022 Q2 | 199.4 Million USD | -2.54% |
| 2022 Q1 | 204.6 Million USD | 196.52% |
| 2022 FY | 152.3 Million USD | 120.72% |
| 2022 Q4 | 152.3 Million USD | -18.64% |
| 2021 FY | 69 Million USD | -49.75% |
| 2021 Q2 | 127.5 Million USD | -8.99% |
| 2021 Q1 | 140.1 Million USD | 2.04% |
| 2021 Q3 | 108 Million USD | -15.29% |
| 2021 Q4 | 69 Million USD | -36.11% |
| 2020 Q3 | 140.2 Million USD | 1.82% |
| 2020 Q4 | 137.3 Million USD | -2.07% |
| 2020 Q1 | 133.6 Million USD | 11.24% |
| 2020 FY | 137.3 Million USD | 14.32% |
| 2020 Q2 | 137.7 Million USD | 3.07% |
| 2019 Q2 | 39.9 Million USD | 228.71% |
| 2019 FY | 120.1 Million USD | 187.79% |
| 2019 Q4 | 120.1 Million USD | 8.69% |
| 2019 Q3 | 110.5 Million USD | 176.94% |
| 2019 Q1 | -31 Million USD | 77.34% |
| 2018 Q2 | -232.2 Million USD | -168.52% |
| 2018 Q3 | -164.2 Million USD | 29.29% |
| 2018 Q4 | -136.8 Million USD | 16.69% |
| 2018 Q1 | 338.9 Million USD | -6.17% |
| 2018 FY | -136.8 Million USD | -137.87% |
| 2017 Q2 | 425.1 Million USD | -2.57% |
| 2017 Q1 | 436.3 Million USD | -6.23% |
| 2017 Q3 | 414.3 Million USD | -2.54% |
| 2017 Q4 | 361.2 Million USD | -12.82% |
| 2017 FY | 361.2 Million USD | -22.37% |
| 2016 Q4 | 465.3 Million USD | -7.44% |
| 2016 Q3 | 502.7 Million USD | -7.73% |
| 2016 Q2 | 544.8 Million USD | 31.79% |
| 2016 Q1 | 413.4 Million USD | -7.85% |
| 2016 FY | 465.3 Million USD | 3.72% |
| 2015 Q3 | 473.4 Million USD | 0.4% |
| 2015 FY | 448.6 Million USD | -7.92% |
| 2015 Q2 | 471.5 Million USD | 0.51% |
| 2015 Q1 | 469.1 Million USD | -3.72% |
| 2015 Q4 | 448.6 Million USD | -5.24% |
| 2014 Q1 | -26.4 Million USD | 18.01% |
| 2014 Q4 | 487.2 Million USD | 1125.68% |
| 2014 Q2 | -38.1 Million USD | -44.32% |
| 2014 FY | 487.2 Million USD | 1613.04% |
| 2014 Q3 | -47.5 Million USD | -24.67% |
| 2013 FY | -32.2 Million USD | -215.0% |
| 2013 Q4 | -32.2 Million USD | 0.0% |
| 2013 Q1 | 47.9 Million USD | 0.0% |
| 2012 FY | 28 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Abbott Laboratories | 8.97 Billion USD | 98.648% |
| Allurion Technologies Inc. | 3.82 Million USD | -3078.01% |
| Artivion, Inc. | 300.4 Million USD | 59.587% |
| Butterfly Network, Inc. | -109.6 Million USD | 210.757% |
| Butterfly Network, Inc. | -109.6 Million USD | 210.757% |
| Bio-Rad Laboratories, Inc. | 1 Billion USD | 87.883% |
| Boston Scientific Corporation | 8.62 Billion USD | 98.593% |
| CONMED Corporation | 966.95 Million USD | 87.445% |
| Edwards Lifesciences Corporation | -449.1 Million USD | 127.032% |
| Paragon 28, Inc. | 36.39 Million USD | -233.599% |
| Glaukos Corporation | 290.27 Million USD | 58.177% |
| Globus Medical, Inc. | 53.11 Million USD | -128.574% |
| Inspire Medical Systems, Inc. | -160.69 Million USD | 175.549% |
| Integer Holdings Corporation | 1.01 Billion USD | 88.066% |
| Medtronic plc | 24.76 Billion USD | 99.51% |
| Myomo, Inc. | -6.27 Million USD | 2036.203% |
| Nevro Corp. | 117.61 Million USD | -3.223% |
| Owlet, Inc. | -1.34 Million USD | 9152.952% |
| Penumbra, Inc. | 66.85 Million USD | -81.582% |
| Vicarious Surgical Inc. | -37.99 Million USD | 419.558% |
| Smith & Nephew plc | 2.78 Billion USD | 95.636% |
| Sonendo, Inc. | 26.34 Million USD | -360.861% |
| STERIS plc | 3.17 Billion USD | 96.178% |
| Stryker Corporation | 10.02 Billion USD | 98.789% |
| Vapotherm, Inc. | 102.66 Million USD | -18.246% |
| Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | 97.824% |